Valuation: Ecomat Inc.

Market Cap 419K 367K 341K 313K 590K 40.44M 599K 4.06M 1.59M 19.79M 1.57M 1.54M 68.35M P/E 2022
-14.8x
P/E 2023 -25x
Enterprise Value 835K 731K 679K 624K 1.18M 80.54M 1.19M 8.09M 3.17M 39.41M 3.13M 3.07M 136M EV / Sales 2022
-
EV / Sales 2023 6,589,581x
Free-Float
8.59%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer 43 2022-09-29
Director TitleAgeSince
Chairman 43 2022-09-29
Change 5-day change 1-year change 3-year change Capi.($)
-57.14%-46.43% - - 714
+2.27%+0.90%+165.31% - 1.11B
+0.74%-1.73%-21.98%+149.16% 715M
+1.60%-1.01%-45.46%+204.08% 501M
0.00%+0.20%-0.79% - 80.92M
Average -10.51%-0.54%+24.27%+176.62% 600.53M
Weighted average by Cap. +1.60%-0.34%+60.02%+171.78%

Financials

2022 2023
Net sales - 0.42 0.37 0.35 0.32 0.6 40.95 0.61 4.11 1.61 20.04 1.59 1.56 69.22
Net income -115K -100K -93.22K -85.66K -161K -11.06M -164K -1.11M -435K -5.41M -430K -421K -18.69M -89.92K -78.79K -73.14K -67.21K -127K -8.68M -129K -871K -341K -4.25M -338K -330K -14.67M
Net Debt 191K 167K 155K 143K 269K 18.44M 273K 1.85M 725K 9.02M 717K 702K 31.17M 416K 364K 338K 311K 585K 40.1M 594K 4.03M 1.58M 19.62M 1.56M 1.53M 67.79M
Logo Ecomat Inc.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Employees
-